205 related articles for article (PubMed ID: 21889317)
1. Triple monoamine inhibitor tesofensine decreases food intake, body weight, and striatal dopamine D2/D3 receptor availability in diet-induced obese rats.
van de Giessen E; de Bruin K; la Fleur SE; van den Brink W; Booij J
Eur Neuropsychopharmacol; 2012 Apr; 22(4):290-9. PubMed ID: 21889317
[TBL] [Abstract][Full Text] [Related]
2. Tesofensine, a novel triple monoamine reuptake inhibitor, induces appetite suppression by indirect stimulation of alpha1 adrenoceptor and dopamine D1 receptor pathways in the diet-induced obese rat.
Axel AM; Mikkelsen JD; Hansen HH
Neuropsychopharmacology; 2010 Jun; 35(7):1464-76. PubMed ID: 20200509
[TBL] [Abstract][Full Text] [Related]
3. Tesofensine induces appetite suppression and weight loss with reversal of low forebrain dopamine levels in the diet-induced obese rat.
Hansen HH; Jensen MM; Overgaard A; Weikop P; Mikkelsen JD
Pharmacol Biochem Behav; 2013 Sep; 110():265-71. PubMed ID: 23932919
[TBL] [Abstract][Full Text] [Related]
4. The triple uptake inhibitor (1R,5S)-(+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0] hexane hydrochloride (DOV 21947) reduces body weight and plasma triglycerides in rodent models of diet-induced obesity.
Tizzano JP; Stribling DS; Perez-Tilve D; Strack A; Frassetto A; Chen RZ; Fong TM; Shearman L; Krieter PA; Tschöp MH; Skolnick P; Basile AS
J Pharmacol Exp Ther; 2008 Mar; 324(3):1111-26. PubMed ID: 18089843
[TBL] [Abstract][Full Text] [Related]
5. High fat/carbohydrate ratio but not total energy intake induces lower striatal dopamine D2/3 receptor availability in diet-induced obesity.
van de Giessen E; la Fleur SE; Eggels L; de Bruin K; van den Brink W; Booij J
Int J Obes (Lond); 2013 May; 37(5):754-7. PubMed ID: 22868829
[TBL] [Abstract][Full Text] [Related]
6. The novel triple monoamine reuptake inhibitor tesofensine induces sustained weight loss and improves glycemic control in the diet-induced obese rat: comparison to sibutramine and rimonabant.
Hansen HH; Hansen G; Tang-Christensen M; Larsen PJ; Axel AM; Raben A; Mikkelsen JD
Eur J Pharmacol; 2010 Jun; 636(1-3):88-95. PubMed ID: 20385125
[TBL] [Abstract][Full Text] [Related]
7. Tesofensine, a monoamine reuptake inhibitor for the treatment of obesity.
Bello NT; Zahner MR
Curr Opin Investig Drugs; 2009 Oct; 10(10):1105-16. PubMed ID: 19777399
[TBL] [Abstract][Full Text] [Related]
8. Striatal dopamine D2/3 receptor availability increases after long-term bariatric surgery-induced weight loss.
van der Zwaal EM; de Weijer BA; van de Giessen EM; Janssen I; Berends FJ; van de Laar A; Ackermans MT; Fliers E; la Fleur SE; Booij J; Serlie MJ
Eur Neuropsychopharmacol; 2016 Jul; 26(7):1190-200. PubMed ID: 27184782
[TBL] [Abstract][Full Text] [Related]
9. Free-choice and no-choice high-fat diets affect striatal dopamine D2/3 receptor availability, caloric intake, and adiposity.
van de Giessen E; la Fleur SE; de Bruin K; van den Brink W; Booij J
Obesity (Silver Spring); 2012 Aug; 20(8):1738-40. PubMed ID: 22307070
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D2/3 receptor availability and amphetamine-induced dopamine release in obesity.
van de Giessen E; Celik F; Schweitzer DH; van den Brink W; Booij J
J Psychopharmacol; 2014 Sep; 28(9):866-73. PubMed ID: 24785761
[TBL] [Abstract][Full Text] [Related]
11. Assessment of metabolic and hormonal profiles and striatal dopamine D2 receptor expression following continuous or scheduled high-fat or high-sucrose diet in rats.
Rospond B; Sadakierska-Chudy A; Kazek G; Krośniak M; Bystrowska B; Filip M
Pharmacol Rep; 2019 Feb; 71(1):1-12. PubMed ID: 30343042
[TBL] [Abstract][Full Text] [Related]
12. The effect of the triple monoamine reuptake inhibitor tesofensine on energy metabolism and appetite in overweight and moderately obese men.
Sjödin A; Gasteyger C; Nielsen AL; Raben A; Mikkelsen JD; Jensen JK; Meier D; Astrup A
Int J Obes (Lond); 2010 Nov; 34(11):1634-43. PubMed ID: 20479765
[TBL] [Abstract][Full Text] [Related]
13. Acutely administered antipsychotic drugs are highly selective for dopamine D2 over D3 receptors.
McCormick PN; Wilson VS; Wilson AA; Remington GJ
Pharmacol Res; 2013 Apr; 70(1):66-71. PubMed ID: 23327779
[TBL] [Abstract][Full Text] [Related]
14. Opposing relationships of BMI with BOLD and dopamine D2/3 receptor binding potential in the dorsal striatum.
Cosgrove KP; Veldhuizen MG; Sandiego CM; Morris ED; Small DM
Synapse; 2015 Apr; 69(4):195-202. PubMed ID: 25664726
[TBL] [Abstract][Full Text] [Related]
15. Anti-hypertensive treatment preserves appetite suppression while preventing cardiovascular adverse effects of tesofensine in rats.
Bentzen BH; Grunnet M; Hyveled-Nielsen L; Sundgreen C; Lassen JB; Hansen HH
Obesity (Silver Spring); 2013 May; 21(5):985-92. PubMed ID: 23784901
[TBL] [Abstract][Full Text] [Related]
16. Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial.
Astrup A; Madsbad S; Breum L; Jensen TJ; Kroustrup JP; Larsen TM
Lancet; 2008 Nov; 372(9653):1906-1913. PubMed ID: 18950853
[TBL] [Abstract][Full Text] [Related]
17. Time-dependent effects of repeated THC treatment on dopamine D2/3 receptor-mediated signalling in midbrain and striatum.
Tournier BB; Tsartsalis S; Dimiziani A; Millet P; Ginovart N
Behav Brain Res; 2016 Sep; 311():322-329. PubMed ID: 27233824
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D3: A Role in Dopamine Circuit Regulation, Diet-Induced Obesity, and Drug Consumption.
Trinko JR; Land BB; Solecki WB; Wickham RJ; Tellez LA; Maldonado-Aviles J; de Araujo IE; Addy NA; DiLeone RJ
eNeuro; 2016; 3(2):. PubMed ID: 27257625
[TBL] [Abstract][Full Text] [Related]
19. Expression of brain derived neurotrophic factor, activity-regulated cytoskeleton protein mRNA, and enhancement of adult hippocampal neurogenesis in rats after sub-chronic and chronic treatment with the triple monoamine re-uptake inhibitor tesofensine.
Larsen MH; Rosenbrock H; Sams-Dodd F; Mikkelsen JD
Eur J Pharmacol; 2007 Jan; 555(2-3):115-21. PubMed ID: 17112503
[TBL] [Abstract][Full Text] [Related]
20. Long-term, calorie-restricted intake of a high-fat diet in rats reduces impulse control and ventral striatal D2 receptor signalling - two markers of addiction vulnerability.
Adams WK; Sussman JL; Kaur S; D'souza AM; Kieffer TJ; Winstanley CA
Eur J Neurosci; 2015 Dec; 42(12):3095-104. PubMed ID: 26527415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
